Elafibranor (Iqirvo) unveiled: a groundbreaking FDA-approved therapy revolutionizing primary biliary cholangitis treatment
Ann Med Surg (Lond)
.
2024 Oct 17;86(12):6910-6912.
doi: 10.1097/MS9.0000000000002672.
eCollection 2024 Dec.
Authors
Iqra Furqan Ahmed
1
,
Fatima Rizwan
1
,
Haleema Mansoor
2
,
Marc Fakhoury
3
,
Muzzamil Hussain Shaik
4
,
Fenil Gandhi
5
,
Christopher Belletieri
6
Affiliations
1
Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
2
Department of Internal Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
3
Department of Medicine, Saint Joseph University of Beirut, Lebanon.
4
Department of Internal Medicine, New vision University, Tbilisi, Georgia.
5
Department of Family Medicine, PGY2, Lower Bucks Hospital, Bristol.
6
Department of Family Medicine, Program Director, Lower Bucks Hospital, Bristol, Pennsylvania, USA.
PMID:
39649939
PMCID:
PMC11623839
DOI:
10.1097/MS9.0000000000002672
No abstract available
Publication types
Editorial